GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (LSE:AZN) » Definitions » Other Gross PPE

AstraZeneca (LSE:AZN) Other Gross PPE : £37 Mil (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Other Gross PPE?

AstraZeneca's Other Gross PPE for the quarter that ended in Dec. 2024 was £37 Mil.

AstraZeneca's quarterly Other Gross PPE increased from Jun. 2024 (£8,515 Mil) to Sep. 2024 (£8,704 Mil) but then declined from Sep. 2024 (£8,704 Mil) to Dec. 2024 (£37 Mil).

AstraZeneca's annual Other Gross PPE increased from Dec. 2022 (£26 Mil) to Dec. 2023 (£28 Mil) and increased from Dec. 2023 (£28 Mil) to Dec. 2024 (£37 Mil).


AstraZeneca Other Gross PPE Historical Data

The historical data trend for AstraZeneca's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Other Gross PPE Chart

AstraZeneca Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.78 24.82 26.27 28.44 37.18

AstraZeneca Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.44 8,354.79 8,514.74 8,703.83 37.18

AstraZeneca Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


AstraZeneca Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.